LimmaTech Biologics AG, a Swiss clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, today announced entry into a definitive agreement to be acquired by ...

Deaths from Staphylococcus aureus–associated lower respiratory tract infections tripled from 1990 to 2021 worldwide.

With an epitope-based immunization, scientists have described a new vaccination strategy against Staphylococcus aureus. After decades of research, the Cologne scientists have now published a new ...

Staphylococcus aureus (S. aureus) is a major cause of skin and soft tissue infections that can sometimes lead to sepsis and toxic shock syndrome. The microbe poses a significant threat to public ...

Plus, who is at the highest risk of catching one.

Staphylococcus aureus is a versatile Gram-positive bacterium capable of causing a spectrum of illnesses ranging from superficial skin infections to life-threatening endocarditis and sepsis. Central to ...

A new study shows efficacy and safety of oral antibiotic therapy, in the form of pills, for Staphylococcus aureus bloodstream infections. Currently, infusions are the standard treatment. An ...

Study shows efficacy and safety of oral antibiotic therapy in the form of pills for Staphylococcus aureus bloodstream infections. Currently, infusions are the standard treatment. An international ...

In a new study, researchers show how so‑called TriPcides can target the bacterium Staphylococcus aureus, including antibiotic‑resistant strains such as MRSA. The compounds disrupt the bacteria's ...

A Wisconsin company is recalling a cream used to treat eczema and other conditions after it was found to be contaminated with Staphylococcus aureus, the Food and Drug Administration announced Tuesday.

The skin bacterium Staphylococcus aureus often develops antibiotic resistance. It can then cause infections that are difficult to treat. Researchers at the University of Bonn have uncovered an ...